Woodfield Clinical Consulting, LLC is a medicine and science based consulting company. The company has a focus on early clinical drug development. It was formed in 2001 by Dr. Neville Ford following his retirement from the Bristol-Myers Squibb Pharmaceutical Research Institute.

Our Goal

The goal of Woodfield Clinical is to add value to your projects. We have accomplished this in a variety of ways for other clients.

  • Developing early development clinical plans to address many of the key issues, exposure/toxicity relationships, PK/PD, DILI, QTc prolongation etc.
  • Making contributions to the clinical development program that refocus it, so that it can provide the data required for key GO/NO GO decisions more expeditiously
  • Preparing for and attending key meetings with regulatory authorities, FDA and European.
  • Helping to prepare and reviewing CTD and NDA documents prior to submission.
  • Assisting with the requirements of the Pediatric Exclusivity Program to obtain additional exclusivity for the product.
  • Appraising licensing opportunities.

The company has also provided advice to law firms involved with pharmaceutical issues.

However, the primary focus of the company is in the drug development process and particularly in the critical early development phase, where opportunities can be overlooked or unrealistic expectations for a project can lead to a squandering of resources.

Woodfield Clinical Consulting, LLC. Copyright 2003.